ENPP2 and metabolic dysfunction-associated steatohepatitis: Upregulation of ATX in chronic liver diseases, including NASH and liver cirrhosis, has been previously observed in animal models, and in human patients (Kaffe et al, 2017; Fujimori et al, 2018).